Terns Pharmaceuticals, Inc.TERNEarnings & Financial Report
Nasdaq
TERN Q3 2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-27.7M
Net Profit
$-24.6M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.27
Terns Pharmaceuticals, Inc. Q3 2025 Financial Summary
Terns Pharmaceuticals, Inc. reported revenue of $0 for Q3 2025, with a net profit of $-24.6M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-24.6M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2025 |
Terns Pharmaceuticals, Inc. Annual Revenue by Year
Terns Pharmaceuticals, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $0).
| Year | Annual Revenue |
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $268.5M | $246.8M | $230.9M | $378.2M | $363.9M | $339.3M | $320.4M | $301.7M |
| Liabilities | $13.2M | $10.0M | $12.2M | $13.8M | $18.1M | $13.3M | $15.2M | $17.6M |
| Equity | $255.4M | $236.7M | $218.7M | $364.5M | $345.9M | $326.0M | $305.2M | $284.1M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-19.3M | $-22.8M | $-16.2M | $-16.5M | $-14.6M | $-24.4M | $-18.9M | $-19.8M |